<DOC>
	<DOCNO>NCT00708604</DOCNO>
	<brief_summary>The purpose study determine safety islet transplantation patient type 1 diabetes successful kidney transplant maintain least three month anti-rejection medication consist combination sirolimus , tacrolimus , MMF prednisone ( 5 mg/day less ) . Another purpose determine effectiveness islet transplant induce insulin independence whether islet transplant improve quality life kidney transplant patient type 1 diabetes .</brief_summary>
	<brief_title>Islet After Kidney Transplantation ( IAK ) Patients With Type 1 Diabetes</brief_title>
	<detailed_description>Insulin hormone help body use sugar keep blood sugar level normal . Special cell human body , call beta cell , make insulin . Beta cell find inside small group cell call `` islet . '' Islets find scattered pancreas gland . Type 1 diabetes cause damage insulin-making cell . Type 1 diabetic patient need insulin shot body make enough insulin . Even insulin shot , many diabetic patient develop damage heart , blood vessel , nerve , eye kidney . Research study suggest problem cause blood sugar level high . Another way treat diabetes give patient pancreas transplant . The pancreas transplant give patient new insulin-making cell . If pancreas transplant work , patient need insulin shot . Pancreas transplantation consider major surgery , thing go wrong surgery . Transplantation islet , rest pancreas , do without major surgery . Research doctor study islet transplantation determine whether subject undergo procedure get insulin shot , without danger major surgery . In 2000 , group research doctor Edmonton , Canada report 3 4 research subject give islet transplant brain-dead donor need insulin shot approximately 2 year transplantation . The research doctor Edmonton also report islet transplant recipient study start need insulin shot longer follow-up . So far , 1 10 research subject original Edmonton trial remain insulin 5 year transplant . The reason islet transplant stop work well enough recipient need start insulin known time . As type transplant , research subject receive islet donor need medicine stop body reject transplant . This study use additional medications/vitamins include Edmonton study may improve long-term outcome islet transplantation . Some research study suggest subject type 1 diabetes , islet transplant may also help kidney transplant work well last longer . This study perform confirm islet kidney transplantation ( IAK ) safe effective procedure kidney transplant patient type 1 diabetes combination sirolimus , tacrolimus , MMF prednisone ( 5 mg per day less ) anti-rejection medication care kidney transplant . Subjects follow closely two year islet transplant monitor blood sugar control , health kidney transplant , change quality life .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Immunosuppressive Agents</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Type 1 diabetes mellitus . Documentation negative basal stimulate Cpeptide ( basal level &lt; /= 0.2 ng/ml IV administration 1 mg glucagon , glucagon stimulate Cpeptide &lt; /= 0.8 ng/ml ) diagnosis diabetes least 5 year . Recipient renal transplant good function ( serum creatinine &lt; /= 1.6 mg/dl , creatinine clearance &gt; /=60 ml/min albumin excretion &lt; /= 300 mg/24 hr ) &gt; 3 month . Stable immunosuppression consist combination sirolimus , tacrolimus , MMF &lt; /= 5 mg/day corticosteroid least 3 month , without major complication . No history acute rejection episode related renal graft last 12 month low risk develop acute rejection ( first renal transplant , PRA &lt; 25 % , negative kidney crossmatch B , T , flow cytometry ) Under continue care renal transplant nephrologist/surgeon . No evidence liver disease ( liver enzymes &lt; twice upper limit normal ALT AST , bilirubin &lt; 2 mg/dl , albumin &gt; 3.5 g/dl , PT PTT &lt; /= 1.1 x upper limit normal ) . Ability comply posttransplant regimen , include immunosuppression , insulin pump therapy metabolic testing . Patients require perform selfmonitoring blood glucose minimum four time daily , provide complete record blood glucose level insulin dos . Ability give inform consent . Age great equal 18 year less equal 65 year . Subjects always manage sirolimus/tacrolimus/MMF/lowdose corticosteroid ( &lt; /=5mg ) immunosuppressive regimen never require conversion must provide sign letter transplant nephrologist /surgeon document . Subjects convert sirolimus/tacrolimus/MMF/lowdose corticosteroid immunosuppressive regimen , must provide proof informed consent regard immunosuppressive conversion one follow format . Subjects convert sirolimus/tacrolimus/MMF/lowdose corticosteroid ( &lt; /=5mg ) due best patient care ( qualify islet transplantation ) must provide sign letter transplant nephrologists/surgeon indicate medical reason ( ) immunosuppression conversion ( date indicate ) . Subjects convert sirolimus/tacrolimus/MMF/lowdose corticosteroid ( &lt; /=5mg ) immunosuppressive regimen purpose qualify islet transplantation must provide sign immunosuppression conversion consent form . Poor renal allograft function ( serum creatinine &gt; 1.6 mg/dl , creatinine clearance &lt; 60ml/min , albumin excretion &gt; 300 mg/24hr ) History acute rejection relate renal graft last 12 month `` high risk '' acute rejection ( one previous renal transplant , PRA &gt; 25 % , positive kidney crossmatch B , T , flow cytometry ) Current immunosuppression therapy corticosteroid &gt; 5mg/day . Significant liver disease ( include elevation liver enzymes &gt; twice upper limit normal ALT AST , bilirubin &gt; 2 mg/dl , albumin &lt; 3.5 g/dl , liver mass include portal vein thrombosis , evidence portal hypertension , significant , untreated gallbladder disease ( i.e. , gallstone ) . Significant cardiovascular disease , include noncorrectable coronary artery disease ejection fraction &lt; 50 % and/or recent myocardial infarction ( within last 12 month ) ; extensive peripheral vascular disease correctable surgery untreated proliferative retinopathy . Recent unresolved acute infection , chronic infection , include tuberculosis , HIV , HBV , HCV , CMV positive skin test TB . Any history malignancy , except squamous basal skin cancer situ cancer cervix . Recent history noncompliance , inability demonstrate capacity comply strict blood glycemic control insulin pump therapy . Psychiatric illness untreated , likely interfere significantly transplantation despite treatment . Presence preform antibody panel reactive antibody screen &gt; 25 % . Body mass index ( BMI ) great 30 . Age le 18 year great 65 year . Presence chronic disease must chronically treat one follow medication : glucocorticoid , diazoxide , bumetanide , haloperidol , chlorpromazine , desipramine , doxepin , imipramine , levodopa , morphine , Lasparaginase , cyclophosphamide , isoniazid , heparin , nalidixic acid , agent may adversely influence glycemic control may confound interpretation Graft Success posttransplant . Pregnant woman , woman intend future pregnancy , woman reproductive potential unable unwilling follow effective contraceptive measure duration immunosuppressive therapy , woman presently breast feed ineligible due unknown effect drug fetus nursing infant . Active alcohol substance abuse , include cigarette smoking ( must abstinent &gt; 3 month ) . Hyperlipidemia ( total cholesterol &gt; 260 mg/dl , LDL &gt; 130 mg/dl , and/or triglyceride &gt; 300 mg/dl ) despite appropriate treatment . Anemia ( Hgb &lt; 12 g/dl ) hematologic disorder require medical attention . Increased risk bleeding ( platelet count &lt; 80,000 ; INR &gt; 1.5 ) , chronic hemostasis disorder , treatment chronic anticoagulant therapy ( i.e. , heparin warfarin ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Kidney Transplantation</keyword>
	<keyword>Islet Transplantation</keyword>
	<keyword>Sirolimus/Tacrolimus/MMF-based Immunosuppressive Regimen</keyword>
</DOC>